Found: 13
Select item for more details and to access through your institution.
VNS Therapy in Treatment-Resistant Depression: Clinical Evidence and Putative Neurobiological Mechanisms.
- Published in:
- 2006
- By:
- Publication type:
- Correction notice
VNS Therapy in Treatment-Resistant Depression: Clinical Evidence and Putative Neurobiological Mechanisms.
- Published in:
- Neuropsychopharmacology, 2006, v. 31, n. 7, p. 1345, doi. 10.1038/sj.npp.1301082
- By:
- Publication type:
- Article
Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia: A Randomized Clinical Trial.
- Published in:
- JAMA Psychiatry, 2024, v. 81, n. 8, p. 749, doi. 10.1001/jamapsychiatry.2024.0785
- By:
- Publication type:
- Article
A call for comparative effectiveness research to learn whether routine clinical care decisions can protect from dementia and cognitive decline.
- Published in:
- Alzheimer's Research & Therapy, 2016, v. 8, p. 1, doi. 10.1186/s13195-016-0200-3
- By:
- Publication type:
- Article
Safety and tolerability of KarXT (xanomeline–trospium) in a phase 2, randomized, double-blind, placebo-controlled study in patients with schizophrenia.
- Published in:
- Schizophrenia (2754-6993), 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41537-022-00320-1
- By:
- Publication type:
- Article
Lessons Learned and Potentials for Improvement in CNS Drug Development: ISCTM Section on Designing the Right Series of Experiments.
- Published in:
- Innovations in Clinical Neuroscience, 2015, v. 12, p. 11S
- By:
- Publication type:
- Article
The TOMMORROW study: Design of an Alzheimer's disease delay‐of‐onset clinical trial.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2019, v. 5, n. 1, p. 661, doi. 10.1016/j.trci.2019.09.010
- By:
- Publication type:
- Article
Effects of pioglitazone on mnemonic hippocampal function: A blood oxygen level–dependent functional magnetic resonance imaging study in elderly adults.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2019, v. 5, n. 1, p. 254, doi. 10.1016/j.trci.2019.05.004
- By:
- Publication type:
- Article
Effectiveness of KarXT (xanomeline-trospium) for cognitive impairment in schizophrenia: post hoc analyses from a randomised, double-blind, placebo-controlled phase 2 study.
- Published in:
- Translational Psychiatry, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41398-022-02254-9
- By:
- Publication type:
- Article
Progress in the tommorrow study: A pharmacogenetics supported clinical trial to delay onset of mild cognitive impairment due to Alzheimer’s disease with low-dose pioglitazone.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P515, doi. 10.1016/j.jalz.2015.06.620
- By:
- Publication type:
- Article
Neuropsychiatry.
- Published in:
- 1997
- By:
- Publication type:
- Book Review
Reduction of platelet serotonin content in depressed patients treated with either paroxetine or desipramine.
- Published in:
- International Journal of Neuropsychopharmacology, 2000, v. 3, n. 3, p. 229, doi. 10.1017/s146114570000198x
- By:
- Publication type:
- Article
Evidence of trospium's ability to mitigate cholinergic adverse events related to xanomeline: phase 1 study results.
- Published in:
- Psychopharmacology, 2023, v. 240, n. 5, p. 1191, doi. 10.1007/s00213-023-06362-2
- By:
- Publication type:
- Article